Julia Teply-Szymanski
4PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 19, 2026
mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR+/HER2- breast cancer.Luise von Wichert, Alina Stroh, Marie Witt
|Jul 04, 2025
Stroma areactive invasion front areas (SARIFA) in 1,298 pT3/pT4 colorectal cancers: A strong prognostic parameter complementing established morphological criteria.Sebastian Foersch, Nuwar Harb, Anne-Sophie Litmeyer
|Jun 23, 2025
Synergistic targeting of cancer cells through simultaneous inhibition of key metabolic enzymes.Jan Dreute, Julia Stengel, Jonas Becher
|Apr 27, 2024
NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors-A Retrospective Molecular Tumor Board Analysis.Niklas Gremke, Fiona R Rodepeter, Julia Teply-Szymanski
Pageof 1
Frequent Collaborators
3 joint publications
Thorsten Stiewe
2 joint publications
Niklas Gremke
1 joint publications
Andreas Neubauer
1 joint publications
Elisabeth K M Mack
1 joint publications
Jan Dreute
1 joint publications
Julia Stengel
1 joint publications
Jonas Becher
1 joint publications
David van den Borre
1 joint publications
Maximilian Pfisterer
1 joint publications
Marek Bartkuhn
